Heterozygous prothrombin gene mutation associated with livedoid vasculopathy

Australasian Journal of Dermatology

Volumn 48, Issue 2, 2007, Pages 120-123

  Anavekar, Namrata S ^a   Kelly, Robert ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Atrophie blanche; Coagulopathy; Livedoid vasculitis; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; CLOPIDOGREL; COLCHICINE; CYCLOSPORIN; DANAZOL; DAPSONE; DICLOFENAC; DIPYRIDAMOLE; HEPARIN; HYDROXYCHLOROQUINE; NIFEDIPINE; PENTOXIFYLLINE; PREDNISOLONE; PROTHROMBIN; SALAZOSULFAPYRIDINE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DRUG TREATMENT FAILURE; ELBOW; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; HYPERBARIC OXYGEN; LEG PAIN; LEG ULCER; LIVEDOID VASCULOPATHY; MUTATIONAL ANALYSIS; SKIN ULCER; SUBCUTANEOUS NODULE; TREATMENT OUTCOME; VASCULAR DISEASE;

ANTICOAGULANTS; FEMALE; HETEROZYGOTE; HUMANS; LEG ULCER; MIDDLE AGED; POINT MUTATION; PROTHROMBIN; SKIN DISEASES, VASCULAR; WARFARIN;

EID: 34249039884     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2007.00350.x     Document Type: Article

References (14)

1. Schroeter AL, Diaz-Perez JL, Winkelman RK, Jordon RE. Livedoid vasculitis (the vasculitis of atrophie blanche). Arch. Dermatol. 1975 111 : 188 93.
2. Maessen-Visch MB, Koedam MI, Hamulyak K, Neumann HA. Atrophie blanche. Int. J. Dermatol. 1999 38 : 161 72.
3. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996 88 : 3698 703.
4. Vicente V, Gonzalez-Conejero R, Rivera J, Corral J. The prothrombin gene variant 20210A in venous and arterial thromboembolism. Haematologica 1999 84 : 356 62.
5. Jorizzo JL. Livedoid vasculopathy: what is it? Arch. Dermatol. 1998 134 : 491 3.
6. Marzano A, Vanotti M, Alessi E. Widespread livedoid vasculopathy. Acta Derm. Venereol. 2003 83 : 457 60.
7. Browning CE, Callen JP. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch. Dermatol. 2006 142 : 75 8.
8. Hegemann B, Helmbold P. Livedoid vasculitis with ulcerations: the role of antithrombin III deficiency and its therapeutic consequences. Arch. Dermatol. 2002 138 : 841 2.
9. Calamia KT, Balabanova M, Perniciaro C, Walsh JS. Livedo (livedoid) vasculitis and the Factor V Leiden mutation: additional evidence for abnormal coagulation. J. Am. Acad. Dermatol. 2002 46 : 133 7.
10. Boyvat A, Kundakci N, Babikir MO, Gurgey E. Livedoid vasculopathy associated with heterozygous protein C deficiency. Br. J. Dermatol. 2000 143 : 840 2.
11. Grasland A, Crickx B, Blanc M, Pouchot J, Vinceneux P. Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies. [French]. Ann. Med. Interne 2000 151 : 408 10.
12. Gotlib J, Kohler S, Reicherter P, Oro AE, Zehnder JL. Heterozygous prothrombin G20210A gene mutation in a patient with livedoid vasculitis. Arch. Dermatol. 2003 139 : 1081 3.
13. Hairston BR, Davis MD, Gibson LE, Drage LA. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. Arch. Dermatol. 2003 139 : 987 90.
14. Klein KL, Pittelkow MR. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clinic Proc. 1992 67 : 923 33.